FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2728778811> ?p ?o ?g. }

• W2728778811 endingPage "747" @default.
• W2728778811 startingPage "737" @default.
• W2728778811 abstract "An observational, prospective, cohort study was performed to compare efficacy and safety of a switch from ritonavir-boosted protease inhibitor (PI/r) to nevirapine or raltegravir with that of rosuvastatin addition to current antiretroviral therapy in HIV-infected patients with hyperlipidaemia.All HIV-infected patients receiving a stable PI/r-based antiretroviral regimen, with persistently suppressed viremia, naïve to non-nucleoside analogues and to integrase strand transfer inhibitors, with mixed hyperlipidaemia, and who underwent a switch from PI/r to nevirapine (Group A) or raltegravir (Group B) or who started rosuvastatin at 10 mg daily (group C) with unchanged antiretroviral regimen were enrolled into the study.Overall, 136 patients were enrolled: 43 patients were included in the group A, 46 in the group B, and 47 in the group C. The mean age was 46.6 years, and 108 (79.4%) were males. After 48 weeks of follow-up, a significantly greater reduction in the mean low-density lipoprotein (LDL) cholesterol level was reported in group C (-28.2%) than in group A (-10.2%; p < .001) and B (-12.4%; p = .021), while a significantly greater reduction in the mean concentration of triglycerides was observed in group A (-31.2%) and B (-35.5%) than in group C (-11.9%; p = .034 and p = .004, respectively). The incidence of adverse events was <10% and comparable across the three groups.In HIV-positive subjects receiving a PI/r, the initiation of rosuvastatin treatment after 48 weeks yielded a greater decline in LDL cholesterol, while the switch from PI/r to nevirapine or raltegravir led to a greater decline in triglycerides." @default.
• W2728778811 created "2017-07-14" @default.
• W2728778811 creator A5013200935 @default.
• W2728778811 creator A5014179891 @default.
• W2728778811 creator A5024975408 @default.
• W2728778811 creator A5039414607 @default.
• W2728778811 creator A5045135007 @default.
• W2728778811 creator A5046270633 @default.
• W2728778811 creator A5048376546 @default.
• W2728778811 creator A5069391747 @default.
• W2728778811 date "2017-07-06" @default.
• W2728778811 modified "2023-09-24" @default.
• W2728778811 title "Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study)" @default.
• W2728778811 cites W1503584044 @default.
• W2728778811 cites W156181957 @default.
• W2728778811 cites W1933845314 @default.
• W2728778811 cites W1964344610 @default.
• W2728778811 cites W1969044505 @default.
• W2728778811 cites W1996083965 @default.
• W2728778811 cites W2001878661 @default.
• W2728778811 cites W2003421870 @default.
• W2728778811 cites W2019071303 @default.
• W2728778811 cites W2025423755 @default.
• W2728778811 cites W2029148240 @default.
• W2728778811 cites W2030599394 @default.
• W2728778811 cites W2056329266 @default.
• W2728778811 cites W2063321514 @default.
• W2728778811 cites W2070903383 @default.
• W2728778811 cites W2076347342 @default.
• W2728778811 cites W2098473115 @default.
• W2728778811 cites W2101105570 @default.
• W2728778811 cites W2105068998 @default.
• W2728778811 cites W2108982499 @default.
• W2728778811 cites W2123055341 @default.
• W2728778811 cites W2137230427 @default.
• W2728778811 cites W2150726018 @default.
• W2728778811 cites W2156188065 @default.
• W2728778811 cites W2159328065 @default.
• W2728778811 cites W2161313492 @default.
• W2728778811 cites W2171603855 @default.
• W2728778811 cites W2260708985 @default.
• W2728778811 cites W2261805462 @default.
• W2728778811 cites W2262405240 @default.
• W2728778811 cites W2277686653 @default.
• W2728778811 cites W2297403101 @default.
• W2728778811 cites W2315744235 @default.
• W2728778811 cites W2318289184 @default.
• W2728778811 cites W2322601374 @default.
• W2728778811 cites W2337988779 @default.
• W2728778811 cites W2405668949 @default.
• W2728778811 cites W4297980317 @default.
• W2728778811 doi "https://doi.org/10.1080/23744235.2017.1339325" @default.
• W2728778811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28683645" @default.
• W2728778811 hasPublicationYear "2017" @default.
• W2728778811 type Work @default.
• W2728778811 sameAs 2728778811 @default.
• W2728778811 citedByCount "4" @default.
• W2728778811 countsByYear W27287788112018 @default.
• W2728778811 countsByYear W27287788112019 @default.
• W2728778811 countsByYear W27287788112020 @default.
• W2728778811 crossrefType "journal-article" @default.
• W2728778811 hasAuthorship W2728778811A5013200935 @default.
• W2728778811 hasAuthorship W2728778811A5014179891 @default.
• W2728778811 hasAuthorship W2728778811A5024975408 @default.
• W2728778811 hasAuthorship W2728778811A5039414607 @default.
• W2728778811 hasAuthorship W2728778811A5045135007 @default.
• W2728778811 hasAuthorship W2728778811A5046270633 @default.
• W2728778811 hasAuthorship W2728778811A5048376546 @default.
• W2728778811 hasAuthorship W2728778811A5069391747 @default.
• W2728778811 hasConcept C120665830 @default.
• W2728778811 hasConcept C121332964 @default.
• W2728778811 hasConcept C126322002 @default.
• W2728778811 hasConcept C142462285 @default.
• W2728778811 hasConcept C159047783 @default.
• W2728778811 hasConcept C197934379 @default.
• W2728778811 hasConcept C2778414717 @default.
• W2728778811 hasConcept C2779130552 @default.
• W2728778811 hasConcept C2779298103 @default.
• W2728778811 hasConcept C2780404665 @default.
• W2728778811 hasConcept C2780499067 @default.
• W2728778811 hasConcept C2781143361 @default.
• W2728778811 hasConcept C2781413609 @default.
• W2728778811 hasConcept C2993143319 @default.
• W2728778811 hasConcept C3013748606 @default.
• W2728778811 hasConcept C61511704 @default.
• W2728778811 hasConcept C71924100 @default.
• W2728778811 hasConcept C90924648 @default.
• W2728778811 hasConcept C98274493 @default.
• W2728778811 hasConceptScore W2728778811C120665830 @default.
• W2728778811 hasConceptScore W2728778811C121332964 @default.
• W2728778811 hasConceptScore W2728778811C126322002 @default.
• W2728778811 hasConceptScore W2728778811C142462285 @default.
• W2728778811 hasConceptScore W2728778811C159047783 @default.
• W2728778811 hasConceptScore W2728778811C197934379 @default.
• W2728778811 hasConceptScore W2728778811C2778414717 @default.
• W2728778811 hasConceptScore W2728778811C2779130552 @default.
• W2728778811 hasConceptScore W2728778811C2779298103 @default.
• W2728778811 hasConceptScore W2728778811C2780404665 @default.

• next